Virginia Commonwealth University

VCU Massey Cancer Center

Massey researcher receives grant funding to support further pre-clinical testing of a promising neuroblastoma therapy

VCU Massey Cancer Center researcher Anthony Faber, Ph.D., was awarded a $250,000 grant from Alex’s Lemonade Stand Foundation to support further laboratory research to provide the validation needed to develop clinical trials to test a new therapy for neuroblastoma, the second deadliest cancer in children.

Continue reading →

Novel model developed to predict nicotine emitted from e-cigarettes

VCU Massey Cancer Center researchers at the VCU Center for the Study of Tobacco Products (CSTP) have developed the first ever, evidence-based model that can predict with up to 90 percent accuracy the amount of nicotine emitted by an electronic cigarette (e-cigarette).

The researchers, working in collaboration with investigators at the American University of Beirut, The model predicted that higher voltage e-cigarette devices paired with high-concentration nicotine liquids could emit greater levels of the addictive substance than those of a traditional tobacco cigarette, depending on user puff duration.

Continue reading →

Twitter chat on coping with cancer

Recently, the National Cancer Institute and the National Institutes of Mental Health co-hosted a Twitter chat on coping with cancer. The discussion focused on the psycho-social aspects of cancer for patients and caregivers across all age groups, and VCU Massey Cancer Center clinical health psychologist, Tamara Orr, Ph.D., M.S., L.C.P., PMHNP-BC, weighed in as the moderator posed a series of questions.

Continue reading →

Massey opens clinical trial testing a combination of Viagra and chemo to treat advanced solid tumors

VCU Massey Cancer Center has developed and opened a Phase 1 clinical trial to study the effects of Viagra in combination with chemotherapy to treat patients with progressive, advanced solid tumors. The trial is a result of previous research conducted at Massey by a group of researchers including physician-scientist Andrew Poklepovic, M.D., who is the leading the trial as its principal investigator. Their research demonstrated that regorafenib (trade name Stivarga), a type of chemotherapy, interacts with Viagra (generic name sildenafil), a medication originally developed for erectile dysfunction, to kill tumor cells significantly better than regorafenib alone.

Continue reading →

Massey researchers find link between cancer gene and obesity

Virginia Commonwealth University Massey Cancer Center researchers have discovered that a gene known to cause cancer also may play a role in determining if someone becomes obese.

Recent discoveries suggest that the gene Astrocyte elevated gene-1 (AEG-1) could even be controlled with certain therapies to prevent or reverse obesity and obesity-related cancers.

Continue reading →